AllianceBernstein Holding LP (AB)

22.75
0.15 0.66
NYSE : Financial
Prev Close 22.90
Open 23.05
Day Low/High 22.70 / 23.15
52 Wk Low/High 16.11 / 25.24
Volume 218.75K
Avg Volume 227.70K
Exchange NYSE
Shares Outstanding 94.72M
Market Cap 2.14B
EPS 1.90
P/E Ratio 9.96
Div & Yield 1.80 (8.00%)

Latest News

Beyond Bitcoin: Big Banks Test Out Blockchain Technology

Beyond Bitcoin: Big Banks Test Out Blockchain Technology

Fourteen banks tested blockchain technology in the syndicated loan market, and benefits were seen.

AB Science Announces The Filing Of Masitinib In The Treatment Of Amyotrophic Lateral Sclerosis (ALS) To The European Medicines Agency

AB Science Announces The Filing Of Masitinib In The Treatment Of Amyotrophic Lateral Sclerosis (ALS) To The European Medicines Agency

Filing of masitinib in the treatment of amyotrophic lateral sclerosis (ALS) to the European Medicines Agency (EMA)

AB Secures First Client For Its Multi-Manager Target-Date Collective Investment Trust Portfolios Funding With $340 Million In Assets

AB Secures First Client For Its Multi-Manager Target-Date Collective Investment Trust Portfolios Funding With $340 Million In Assets

Financial Services Client Moves from Passive to Hybrid Solution Including Active Management

Align With AllianceBernstein for Income

Align With AllianceBernstein for Income

This master limited partnership offers high cash payout without taking on undue risk.

AB Statement On Visium Transaction

AB Statement On Visium Transaction

Don't Miss Out: Top 3 Yielding Buy-Rated Stocks: NEWT, AB, CORR

Don't Miss Out: Top 3 Yielding Buy-Rated Stocks: NEWT, AB, CORR

These 3 dividend stocks are rated a Buy by TheStreet

Best 3 Yielding Buy-Rated Stocks: NEWT, AB, CORR

Best 3 Yielding Buy-Rated Stocks: NEWT, AB, CORR

These 3 dividend stocks are rated a Buy by TheStreet

AB Science Announces The Publication In The Journal Of Neuroinflammation Of Preclinical Data Showing Neuroprotective Effect Of Masitinib In Amyotrophic Lateral Sclerosis

AB Science Announces The Publication In The Journal Of Neuroinflammation Of Preclinical Data Showing Neuroprotective Effect Of Masitinib In Amyotrophic Lateral Sclerosis

Publication in the Journal of Neuroinflammation of preclinical data showing neuroprotective effect of masitinib in amyotrophic lateral sclerosis, through targeting of microglial cells

Hedge Funder Found Dead After Insider Trading Charges: Details Emerge

Hedge Funder Found Dead After Insider Trading Charges: Details Emerge

Visium partner Sanjay Valvani found dead at 44, less than a week after he was indicted on insider trading and fraud charges.

AB Science Announces That Rapporteurs Appointed By The EMA Have Recommended The Filing Of Masitinib In ALS For Conditional Marketing Authorization

AB Science Announces That Rapporteurs Appointed By The EMA Have Recommended The Filing Of Masitinib In ALS For Conditional Marketing Authorization

Filing at EMA for conditional marketing authorization is expected by Q3 2016

3 Buy-Rated Dividend Stocks Leading The Pack: CLCT, PFLT, AB

3 Buy-Rated Dividend Stocks Leading The Pack: CLCT, PFLT, AB

These 3 dividend stocks are rated a Buy by TheStreet

AB Science Will Present Phase 3 Data In Severe Systemic Mastocytosis At The International 21st Congress Of The European Hematology Association

AB Science Will Present Phase 3 Data In Severe Systemic Mastocytosis At The International 21st Congress Of The European Hematology Association

Abstract Selected for Oral presentation by the EHA Scientific Program Committee

3 Stocks Going Ex-Dividend Tomorrow: ARCX, AB, DLB

3 Stocks Going Ex-Dividend Tomorrow: ARCX, AB, DLB

ARCX AB DLB are going ex-dividend tomorrow, Thursday, May 05, 2016

Buy-Rated Dividend Stocks: Top 3 Companies: PFLT, AB, GBDC

Buy-Rated Dividend Stocks: Top 3 Companies: PFLT, AB, GBDC

These 3 dividend stocks are rated a Buy by TheStreet